en

PRODUCT DETAIL

Omvoh 300 mg koncentrát na infúzny roztok

Code 3765E
MA number EU/1/23/1736/001
Product Form: con inf 1x15 ml/300 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Eli Lilly Nederland B.V., Netherland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC24 Mirikizumab
Shelf life: 24
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 26.05.2023
Validity: 26.05.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 12.06.2023
eu-flag.png sk-flag.png